starts with
Recently, Capital Medical University president and biologist Rao Yi said in an interview with reporters: There is no need to rush to buy Lianhua Qingwen, I will throw it away if it is given away.
What is the situation? Rao Yi is a biologist, a professor at Peking University and Capital Medical University, and a doctoral supervisor. He is also a big shot. Why does he have such opinions about Lianhua Qingwen?
But we are not in the medical field, so I don’t want to make any judgments. Fortunately, I also have another skill, which is to look up information and gather history.
During the SARS period in 2003, when the SARS virus first came out, many experts did not know how to solve it.
At this time, a Hebei company called Yiling Pharmaceutical , through engineers working day and night, completed a capsule that can eliminate the virus in just 15 days, and named it Lianhua Qingwen.
Although in the end when it was approved for sale, SARS had been brought under control and Lianhua Qingwen’s true skills were not seen.
But when the new coronavirus epidemic occurred, this drug became the "Chosen One" again.
There is even a well-known Professor Zhong Moushan who has supported Lianhua Qingwen in public many times. For example, in May 2022, when invited by the Ministry of Foreign Affairs and the National Health Commission to answer questions about the "epidemic" for overseas students, he said conclusively: "There is sufficient evidence to prove that Lianhua Qingwen is effective in treating new coronavirus pneumonia ."
It goes without saying how high Zhong Moushan’s status is. Anyway, as soon as this statement came out, it made Lianhua Qingwen very popular in the country. It suddenly became the number one "miraculous drug" for the prevention and control of the new crown epidemic, and everyone in the country knew it.
The sales volume of Lianhua Qingwen is like riding on a rocket, rising steadily, ranking first in the ranking of over-the-counter drugs on a third-party platform. At the same time, Wu Yiling, the boss of Yiling Pharmaceutical, made a lot of money, and his net worth soared to 23 billion.
So is Lianhua Qingwen really a miracle drug?
Lianhua Qingwen
Whether the miracle drug is effective or not, it is definitely useless for the manufacturer to just say it by word of mouth. It is still necessary to provide evidence to convince people.
So in 2020, Lianhua Qingwen launched a prospective, randomized, controlled, multi-center clinical study on the treatment of COVID-19.
The study was jointly completed by Wuhan University People's Hospital and 23 hospitals in 9 provinces across the country. A third-party CRO company was responsible for supervision and quality control, and a third-party statistical unit completed data management and statistical analysis to ensure its objectivity and scientificity. After a related clinical trial,
found that the drug’s improvement rate in the main clinical symptoms of COVID-19 (fever, fatigue, cough, etc.) was significantly higher than that in the control group.
Later, Yiling Pharmaceutical published the research results in the internationally renowned botanical medicine journal "Phtomedicine". There is a passage in it, which states that the positive rate of nucleic acid test for in the Lianhua Qingwen intervention group was 0.27%, which was significantly lower than the positive rate of 1.14% in the control group (statistically significant). The preventive application of Lianhua Qingwen in close contact groups can reduce the positive infection rate of COVID-19 by 76%, and is safe at the same time. At first glance,
can reduce so much, which seems to be a good thing, but there are always caveats in everything.
According to professionals who have read this paper carefully, there is a significant correlation between taking Lianhua Qingwen and reducing the overall infection rate of contacts. However, this significant correlation was not observed in close contacts, but was only detected in sub-close contacts.
This result makes people confused like a Zhang Er monk. It is only useful for sub-close connections, but has no effect on close connections. Is this a lonely test? The prevention of
is like this, but what about the consequences after infection?
No, Yiling Pharmaceutical released a related paper saying that Lianhua Qingwen has a significant effect on alleviating infections. However, it was later dug out. The person behind the scenes who wrote the paper turned out to be the son-in-law of Wu Yiling, the founder of Yiling Pharmaceutical.
Well, I don’t know if there is any profit transfer, but let’s talk about the data. Anyway, part of the funds for related research comes from Yiling Pharmaceutical. So everyone should be able to understand.
I guess many people have asked, there are many drugs like Lianhua Qingwen that can only alleviate the symptoms of the new coronavirus cold, but why did it finally get out of the circle?
is nothing but good at marketing.
First of all, the name of the drug Lianhua Qingwen is very particular.
The ingredients in this medicine include Forsythia , Silver Flower , Isatis root , Rhodiola rosea , Patchouli and other Chinese herbal formulas. The founder abbreviated Forsythia suspensa and honeysuckle together as "Lianhua" to tell consumers, look, this is a natural Chinese patent medicine.
Add the word "Qingwen", and the literal meaning can be seen that it can clear the "plague". China has collectively referred to malignant infectious diseases as plague since ancient times, so it can be easily tied to the current epidemic.
Secondly, Yiling Pharmaceutical is willing to spend huge sums of money on promotion, and it is focusing on hot spots everywhere. In the past five years, Yiling Pharmaceutical has invested a total of more than 8 billion yuan in promotion fees, and the annual promotion fee is close to 80% of sales expenses.
SARS was reported in 2003, bird flu was reported in 2005, hand, foot and mouth disease was reported in 2008, Influenza A H1N1 was reported in 2009, and COVID-19 was reported in 2020 Epidemics, etc...
Coupled with the basic seasonal influenza situation every winter, it can be said that Lianhua Qingwen has not missed any business opportunities brought by the virus pandemic. It can find a marketing entry point for every epidemic, and gradually formed a positioning layout of a medicine that can treat a variety of diseases.
No wonder someone said that there are two kinds of medicine in the world that can cure all diseases, one is called drinking more hot water, and the other is called Lianhua Qingwen.
Let’s go back to Rao Yi, the president of Capital Medical University at the beginning. On December 19, 2022, this big shot published an article titled "You don’t have to show off your strength when dealing with superiors, and you shouldn’t be aggressive when dealing with subordinates. Representatives on both sides of the epidemic should seek truth from facts." Most of the article is about the fight between gods. If readers are interested, you can read the original text.
In the second half of the article, Professor Rao Yi quoted two papers to express doubts about Lianhua Qingwen. He believed that the new coronavirus clinical trial could be completed within a few months, but Lianhua Qingwen’s phase 3 double-blind randomized controlled clinical trial has not yet been completed, so its effectiveness needs to be verified.
ends with
. If Lianhua Qingwen Capsules is just an appetizer, then Yiling Pharmaceutical has another showy operation, which makes people feel a little confused.
No, the company recently applied for another patent. They invented a spunbond non-woven fabric containing Lianhua Qingwen extract.
This kind of cloth is amazing. It can be made into many things, such as Lianhua Qingwen masks, underwear, underwear, masks, socks, gloves, scarves, and even protective glasses.
Good guy, this is trying to squeeze out every inch of Lianhua Qingwen’s value. After this operation, it doesn’t matter whether the market can accept it or not, as long as the stock price of and rises.
According to Yiling Pharmaceutical’s disclosure, in 2021, the company’s Lianhua Qingwen products achieved operating income of 4.06 billion yuan, accounting for 40.15% of the company’s total operating income. In terms of
market share, according to the company's 2021 semi-annual report data, Lianhua Qingwen's products ranked first in the sales ranking of proprietary cold medicines in the public medical market in 2020, with a market share of 33.5%.
In terms of stock price, from September 26 to December 8 this year, Yiling Pharmaceutical rose from 18.8 yuan to 53.96 yuan within 48 trading days, an increase of of 287%.
At present, the market value of Yiling Pharmaceutical is 85 billion yuan. In 2019, this number was 12 billion yuan; a small box of Lianhua Qingwen created a huge wealth of more than 70 billion yuan in just three years.
As for whether Lianhua Qingwen is effective or even has side effects, these are things that experts should consider. But for this special moment, which drug is the most effective, I believe the market can give the final answer. There are some things in
. Over-deification is actually digging a hole for yourself. No one is the god of medicine, and no one's medicine can cure all diseases. The most important thing is to make good products honestly and down-to-earth.
